Regeneron Pharmaceuticals (REGN)

$1,063.60 3.66 (0.34%)

16:00 EDT REGN Stock Quote Delayed 30 Minutes

3 Standout Stocks to Buy for the Next Bull Market

By Tezcan Gecgil, InvestorPlace Contributor Jul 18, 2024

These standout stocks to buy for a bull market offer promising potential for significant gains as market conditions continue to strengthen.

Stocks to Buy: 7 Founder-Led Companies Set to Outperform

3 Pharma Stocks Already Ushering in the Next Biotech Boom

7 High Priced Stocks That Would Benefit From a Stock Split

Volume:

Previous Close -

Market Cap 97.62B

PE Ratio 31.41

EPS 33.86

Volume (Avg. Vol.) 452,212

Day's Range $1,060.74 - $1,076.74

52-Week Range $721.51 - $1,106.16

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

3 Biotech Stocks That Could Make Your Grandchildren Rich

By Mohammed Saqib, InvestorPlace Contributor Jun 27, 2024

These biotech stocks are poised to generate significant returns to investors due to their high growth potential.

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

By Josh Enomoto, InvestorPlace Contributor May 20, 2024

Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying prioritization. While the media focuses on attaining wealth, that doesn’t…

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire

By Joel Lim, InvestorPlace Contributor May 4, 2024

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

By Matthew Farley, InvestorPlace Contributor May 3, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

REGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

REGN stock results show that Regeneron Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

3 Biotech Stocks to Buy for the Next Bull Run: March 2024

By Mohammed Saqib, InvestorPlace Contributor Mar 26, 2024

These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs

By Chris MacDonald, InvestorPlace Contributor Mar 22, 2024

The market for weight loss drug stocks is massive, and these three companies could be the biggest beneficiaries of this trend.

The 3 Most Undervalued Biotech Stocks to Buy in March 2024

By Chandler Capital, InvestorPlace Contributor Mar 13, 2024

These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

By Will Ashworth, InvestorPlace Contributor Mar 4, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

3 Top Pharma Stocks to Buy Now: February 2024

By Rick Orford, InvestorPlace Contributor Feb 1, 2024

Take a look at why these three buy-rated pharma stocks could be your ticket to explosive portfolio growth.

3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor Jan 23, 2024

Blue-chip healthcare stocks combine stability, profitability, and long-term growth prospects into a single investable package.

Healthcare Heroes: 3 Biotech Stocks Poised to Cure What Ails the Market

By Jeremy Flint, InvestorPlace Contributor Jan 16, 2024

Biotech stocks are set to rebound in 2024 as the FDA accelerates its approval pace and cash flows back into the industry.

7 Undervalued Nasdaq-100 Stocks for Bargain Hunters

By Josh Enomoto, InvestorPlace Contributor Dec 21, 2023

Understandably, with the innovation sector printing a remarkable performance, all eyes have centered on Nasdaq-100 stocks. Indeed, on a year-to-date basis, the index shot up…

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

By Josh Enomoto, InvestorPlace Contributor Nov 9, 2023

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…